Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Mayo Clinic Proceedings
|
February 5, 2025
Academic Promotions in Medicine: Characterizing Differences in Curriculum Vitae Across Race and Sex
Rahma Warsame, Yong-Hun Kim, Melody Y Ouk, et al.
American Journal of Hematology
|
February 2, 2021
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy
Kebede H Begna, Naseema Gangat, Aref Al-Kali, et al.
Blood
|
July 27, 2006
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients
Animesh D Pardanani, Ross L Levine, Terra Lasho, et al.
American Journal of Hematology
|
April 23, 2014
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients
Ayalew Tefferi, Emnet A Wassie, Paola Guglielmelli, et al.
Blood Cancer Journal
|
February 14, 2018
Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts
Abhishek A Mangaonkar, Terra L Lasho, Christy M Finke, et al.
British Journal of Haematology
|
August 4, 2021
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases
Kebede H Begna, Jaya Kittur, Jennifer Yui, et al.
Leukemia & Lymphoma
|
October 24, 2012
Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy
Ming Y Lim, Aref Al-Kali, Aneel A Ashrani, et al.
American Journal of Hematology
|
September 20, 2018
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Mayo Clinic Proceedings
|
March 3, 2019
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
Natasha Szuber, Mythri Mudireddy, Maura Nicolosi, et al.
Blood Cancer Journal
|
March 3, 2021
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Mayo Clinic Proceedings
|
February 5, 2025
Academic Promotions in Medicine: Characterizing Differences in Curriculum Vitae Across Race and Sex
Rahma Warsame, Yong-Hun Kim, Melody Y Ouk, et al.
American Journal of Hematology
|
February 2, 2021
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy
Kebede H Begna, Naseema Gangat, Aref Al-Kali, et al.
Blood
|
July 27, 2006
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients
Animesh D Pardanani, Ross L Levine, Terra Lasho, et al.
American Journal of Hematology
|
April 23, 2014
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients
Ayalew Tefferi, Emnet A Wassie, Paola Guglielmelli, et al.
Blood Cancer Journal
|
February 14, 2018
Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts
Abhishek A Mangaonkar, Terra L Lasho, Christy M Finke, et al.
British Journal of Haematology
|
August 4, 2021
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases
Kebede H Begna, Jaya Kittur, Jennifer Yui, et al.
Leukemia & Lymphoma
|
October 24, 2012
Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy
Ming Y Lim, Aref Al-Kali, Aneel A Ashrani, et al.
American Journal of Hematology
|
September 20, 2018
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Mayo Clinic Proceedings
|
March 3, 2019
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
Natasha Szuber, Mythri Mudireddy, Maura Nicolosi, et al.
Blood Cancer Journal
|
March 3, 2021
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Page
of 8